LRP5 signaling in osteosarcomagenesis

A cautionary tale of translation from cell lines to tumors

Logan Horne, Frank R. Avilucea, Huifeng Jin, Jared J. Barrott, Kyllie Smith-Fry, Yanliang Wang, Bang H. Hoang, Kevin B. Jones

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Previous reports document expression of low-density lipoprotein receptor-related protein 5 (LRP5) in osteosarcoma (OS) tissue. Expression of this Wnt receptor correlated with metastatic disease and poor disease-free survival. Forced expression of dominant-negative LRP5 (dnLRP5), which lacks the membrane binding domain of the native protein and therefore functions as a soluble receptor-sponge for Wnt ligands, reduced in vitro cellular invasion and in vivo xenograft tumor growth for osteosarcoma cell lines. Here, we use a genetically engineered mouse model of osteosarcomagenesis with and without expression of dnLRP5 to assess to what degree tumorigenesis is affected and whether Wnt/β-catenin signaling is circumvented or maintained. Each cohort of mice developed osteosarcoma at a similar ultimate prevalence, but after a slightly increased latency in those also expressing dnLRP5. On histology, there was no difference between groups, despite previous reports that the dnLRP5 osteosarcoma cells specifically undergo a mesenchymal-to-epithelial transition in vitro. Finally, immunohistochemistry showed the presence of cytosolic and nuclear β-catenin and nuclear Cyclin D1, markers consistent with preserved Wnt/β-catenin signaling despite constitutive blockade of the cell surface receipt of Wnt signaling ligand. These data suggest that canonical Wnt signaling plays a role in OS progression and that while blockade of singular nodes in signaling pathways can have dramatic effects on individual cell lines, real tumors readily evade such focused attacks.

Original languageEnglish (US)
Pages (from-to)438-444
Number of pages7
JournalTranslational Oncology
Volume9
Issue number5
DOIs
StatePublished - Oct 1 2016

Fingerprint

Low Density Lipoprotein Receptor-Related Protein-5
Osteosarcoma
Tumor Cell Line
Catenins
Wnt Receptors
Ligands
Epithelial-Mesenchymal Transition
Cyclin D1
Porifera
Heterografts
Disease-Free Survival
Histology
Carcinogenesis
Immunohistochemistry
Cell Line
Membranes
Growth

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Horne, L., Avilucea, F. R., Jin, H., Barrott, J. J., Smith-Fry, K., Wang, Y., ... Jones, K. B. (2016). LRP5 signaling in osteosarcomagenesis: A cautionary tale of translation from cell lines to tumors. Translational Oncology, 9(5), 438-444. https://doi.org/10.1016/j.tranon.2016.08.010

LRP5 signaling in osteosarcomagenesis : A cautionary tale of translation from cell lines to tumors. / Horne, Logan; Avilucea, Frank R.; Jin, Huifeng; Barrott, Jared J.; Smith-Fry, Kyllie; Wang, Yanliang; Hoang, Bang H.; Jones, Kevin B.

In: Translational Oncology, Vol. 9, No. 5, 01.10.2016, p. 438-444.

Research output: Contribution to journalArticle

Horne, L, Avilucea, FR, Jin, H, Barrott, JJ, Smith-Fry, K, Wang, Y, Hoang, BH & Jones, KB 2016, 'LRP5 signaling in osteosarcomagenesis: A cautionary tale of translation from cell lines to tumors', Translational Oncology, vol. 9, no. 5, pp. 438-444. https://doi.org/10.1016/j.tranon.2016.08.010
Horne, Logan ; Avilucea, Frank R. ; Jin, Huifeng ; Barrott, Jared J. ; Smith-Fry, Kyllie ; Wang, Yanliang ; Hoang, Bang H. ; Jones, Kevin B. / LRP5 signaling in osteosarcomagenesis : A cautionary tale of translation from cell lines to tumors. In: Translational Oncology. 2016 ; Vol. 9, No. 5. pp. 438-444.
@article{5790f61d43e94fca8a688a445d9531e7,
title = "LRP5 signaling in osteosarcomagenesis: A cautionary tale of translation from cell lines to tumors",
abstract = "Previous reports document expression of low-density lipoprotein receptor-related protein 5 (LRP5) in osteosarcoma (OS) tissue. Expression of this Wnt receptor correlated with metastatic disease and poor disease-free survival. Forced expression of dominant-negative LRP5 (dnLRP5), which lacks the membrane binding domain of the native protein and therefore functions as a soluble receptor-sponge for Wnt ligands, reduced in vitro cellular invasion and in vivo xenograft tumor growth for osteosarcoma cell lines. Here, we use a genetically engineered mouse model of osteosarcomagenesis with and without expression of dnLRP5 to assess to what degree tumorigenesis is affected and whether Wnt/β-catenin signaling is circumvented or maintained. Each cohort of mice developed osteosarcoma at a similar ultimate prevalence, but after a slightly increased latency in those also expressing dnLRP5. On histology, there was no difference between groups, despite previous reports that the dnLRP5 osteosarcoma cells specifically undergo a mesenchymal-to-epithelial transition in vitro. Finally, immunohistochemistry showed the presence of cytosolic and nuclear β-catenin and nuclear Cyclin D1, markers consistent with preserved Wnt/β-catenin signaling despite constitutive blockade of the cell surface receipt of Wnt signaling ligand. These data suggest that canonical Wnt signaling plays a role in OS progression and that while blockade of singular nodes in signaling pathways can have dramatic effects on individual cell lines, real tumors readily evade such focused attacks.",
author = "Logan Horne and Avilucea, {Frank R.} and Huifeng Jin and Barrott, {Jared J.} and Kyllie Smith-Fry and Yanliang Wang and Hoang, {Bang H.} and Jones, {Kevin B.}",
year = "2016",
month = "10",
day = "1",
doi = "10.1016/j.tranon.2016.08.010",
language = "English (US)",
volume = "9",
pages = "438--444",
journal = "Translational Oncology",
issn = "1936-5233",
publisher = "Neoplasia Press",
number = "5",

}

TY - JOUR

T1 - LRP5 signaling in osteosarcomagenesis

T2 - A cautionary tale of translation from cell lines to tumors

AU - Horne, Logan

AU - Avilucea, Frank R.

AU - Jin, Huifeng

AU - Barrott, Jared J.

AU - Smith-Fry, Kyllie

AU - Wang, Yanliang

AU - Hoang, Bang H.

AU - Jones, Kevin B.

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Previous reports document expression of low-density lipoprotein receptor-related protein 5 (LRP5) in osteosarcoma (OS) tissue. Expression of this Wnt receptor correlated with metastatic disease and poor disease-free survival. Forced expression of dominant-negative LRP5 (dnLRP5), which lacks the membrane binding domain of the native protein and therefore functions as a soluble receptor-sponge for Wnt ligands, reduced in vitro cellular invasion and in vivo xenograft tumor growth for osteosarcoma cell lines. Here, we use a genetically engineered mouse model of osteosarcomagenesis with and without expression of dnLRP5 to assess to what degree tumorigenesis is affected and whether Wnt/β-catenin signaling is circumvented or maintained. Each cohort of mice developed osteosarcoma at a similar ultimate prevalence, but after a slightly increased latency in those also expressing dnLRP5. On histology, there was no difference between groups, despite previous reports that the dnLRP5 osteosarcoma cells specifically undergo a mesenchymal-to-epithelial transition in vitro. Finally, immunohistochemistry showed the presence of cytosolic and nuclear β-catenin and nuclear Cyclin D1, markers consistent with preserved Wnt/β-catenin signaling despite constitutive blockade of the cell surface receipt of Wnt signaling ligand. These data suggest that canonical Wnt signaling plays a role in OS progression and that while blockade of singular nodes in signaling pathways can have dramatic effects on individual cell lines, real tumors readily evade such focused attacks.

AB - Previous reports document expression of low-density lipoprotein receptor-related protein 5 (LRP5) in osteosarcoma (OS) tissue. Expression of this Wnt receptor correlated with metastatic disease and poor disease-free survival. Forced expression of dominant-negative LRP5 (dnLRP5), which lacks the membrane binding domain of the native protein and therefore functions as a soluble receptor-sponge for Wnt ligands, reduced in vitro cellular invasion and in vivo xenograft tumor growth for osteosarcoma cell lines. Here, we use a genetically engineered mouse model of osteosarcomagenesis with and without expression of dnLRP5 to assess to what degree tumorigenesis is affected and whether Wnt/β-catenin signaling is circumvented or maintained. Each cohort of mice developed osteosarcoma at a similar ultimate prevalence, but after a slightly increased latency in those also expressing dnLRP5. On histology, there was no difference between groups, despite previous reports that the dnLRP5 osteosarcoma cells specifically undergo a mesenchymal-to-epithelial transition in vitro. Finally, immunohistochemistry showed the presence of cytosolic and nuclear β-catenin and nuclear Cyclin D1, markers consistent with preserved Wnt/β-catenin signaling despite constitutive blockade of the cell surface receipt of Wnt signaling ligand. These data suggest that canonical Wnt signaling plays a role in OS progression and that while blockade of singular nodes in signaling pathways can have dramatic effects on individual cell lines, real tumors readily evade such focused attacks.

UR - http://www.scopus.com/inward/record.url?scp=84991712857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991712857&partnerID=8YFLogxK

U2 - 10.1016/j.tranon.2016.08.010

DO - 10.1016/j.tranon.2016.08.010

M3 - Article

VL - 9

SP - 438

EP - 444

JO - Translational Oncology

JF - Translational Oncology

SN - 1936-5233

IS - 5

ER -